|
|
News Breaks
|
June 27, 2011
|
| 09:09 EDT |  | CXM |
| theflyonthewall.com: | Cardium Therapeutics acquires Transdel's business assets for up to $4M | | Cardium Therapeutics announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel, which is a topically-administered analgesic for the treatment of musculoskeletal pain. The business assets would be acquired in connection with a proposed asset purchase under Section 363 of Chapter 11 of the U.S. Bankruptcy Code, and would also include royalty-bearing license agreements for certain cosmeceutical products marketed by third parties that employ Transdel delivery technology. Under the terms of the asset purchase agreement, which remains subject to the satisfaction of various conditions including approval of the transaction by the Federal bankruptcy court, Cardium would acquire substantially all of Transdel's business assets for the payment of up to $4M in consideration in the form of unregistered shares of Cardium common stock priced at a minimum of 50c per share. :theflyonthewall.com |
|
|
News For CXM From The Last 14 Days Check below for free stories on CXM the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 21, 2012
|
| 07:38 EDT |  | CXM |
|
|
|
|
|
Subscribe for More Information